- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson’s Disease
- A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA®
- Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson’s Disease
- A Study to Evaluate the Effects of ACI-7104.056 Vaccination in Patients With Early Stages of Parkinson’s Disease
- Early Parkinson’s Disease Monotherapy With CVN424
- A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson’s Disease (PD)
- Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson’s Disease
- A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
- Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Established Parkinson’s Disease Experiencing OFF Episodes
- Pentoxifylline and Parkinsonism
- Effect of Folic Acid on Motor Aspects of Daily Living and Oxidative Stress in Levodopa Treated Parkinson’s Disease Patients
- PF-06669571 In Subjects With Idiopathic Parkinson’s Disease
- Study to Assess PDM608 in Healthy Adult Subjects
- Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson’s Disease
- Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson’s Disease
- Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson’s Disease Patients.
- Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson’s Disease Related Constipation
- A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson’s Disease
- Single Ascending Doses of HER-096 in Healthy Subjects
- Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson’s Disease
- Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson’s Disease
- Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients
- Safety and Efficacy Study of KL002 in the Treatment of Advanced Primary PD
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers
- i-BiSSkApp for Swallowing Rehabilitation in Parkinson’s Disease
- Non-drug Treatment Study in Parkinson’s Disease Patients and Healthy Volunteers to Collect Biological Samples in Order to Assess ex Vivo the Activity of Candidate Therapies and Develop Novel Analytical Methods for Biomarkers
- The Dutch Parkinson GBA Ambroxol Trial (DUPARG-AMBROXOL)
- Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson’s Disease Related Psychosis
- Safety and Efficacy Study of Parkinson’s Disease Gene Therapy Drug (BBM-P002)
- Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
- Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson’ Disease
- A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson’s Disease
- Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson’s Disease
- Pimavanserin for Sleep in Parkinson Disease
- Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101
- Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson’s Disease
- Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
- Ambroxol to Slow Progression in Parkinson Disease
- Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson’s Disease
- Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson’s Disease (PD)
